ACT Health have engaged ATODA to research, scope and design a pilot project to provide more effective responses for people who use alcohol and other drugs (AOD) in harmful ways and either experience domestic and family violence (DFV) or are at risk of using DFV. Included in this, is an expectation that ATODA will:
- Research, scope and design a pilot project (for delivery at a later point);
- Engage expert clinical expertise;
- Develop an evaluation plan;
- Identify and consult with key stakeholders; and,
- Consider key partnerships for implementation of the pilot project.
The project is conceptualised as a long-term multi-year project to increase the capacity of the ACT drug treatment system, services and staff to deliver programs that reflect best practice in DFV prevention and responses. Year 1 of this funding will focus on developing the infrastructure and framework for this work to occur in subsequent years (with roll out to AOD services planned from 2018).
Pilot Project Vision
The vision is for an ACT AOD specialist sector that provides both specialist integrated clinical AOD / DFV interventions as well as universal identification and responses to DFV that reflect best practice and meet community expectations of safety.
Pilot Project Model
The pilot program will undertake a series of short and long term activities concurrently, whereby service delivery will be strengthened across the entire system alongside the development of specialist integrated AOD treatment and DFV interventions to meet the clinical, therapeutic and other needs of people who use AOD in harmful ways and either experience DFV or are at risk of using DFV. It is expected that in later years, the capacity of all services to identify and respond to DFV will be part of routine practice; and a provider (or multiple providers) will by delivering program/s that offer concurrent and integrated AOD treatment and DFV clinical / therapeutic programs (this could include both therapeutic programs for women who experience DFV; and behaviour change programs for men who use DFV). A visual description of the project model is provided below.
Year 1 Objectives:
- Engage and liaise with AOD specialist treatment and support services and other key stakeholders (including through the DFV sector) to scope the existing capacity and needs around integrating DFV into routine AOD practice.
- Design a multi-year Pilot Project that will facilitate the development of both collective capacity around DFV across all services in the AOD sector, and specific and targeted clinical DFV capacity within individual services.
- Develop an evaluation plan and recruit an external evaluation team to monitor and measure the Program’s implementation and impact.
- Recruit clinicians with specialist AOD and DFV expertise to provide advice on project design and implementation.
- Develop a tool that will collect baseline information from participating services on DFV capabilities that can be readministered at regular intervals to assess increased capacity.
The Project is guided by an Advisory Group whose primary function is to provide high level advice, strategic guidance and governance to the Project. This will include:
- Supporting transparent and inclusive processes for the development and implementation of the Project
- Providing input into development of Project materials
- Identifying appropriate stakeholders to participate in Project consultative mechanisms
- Contributing information on interrelated activities relevant to AOD / DFV including policy, service delivery and governance
- Identifying and communicating barriers, challenges and successes regarding the implementation of the Project.
- Supporting communication about the Project within networks and interrelated activities, including ensuring information about the Project is available to specialist AOD services.
More information will be available shortly.
The Promoting Safety and Prioritising Domestic and Family Violence in the ACT Alcohol and Other Drug Sector Symposium was a key step in bringing the various parts of the ACT AOD sector together (workers, consumers, researchers, policy makers and service providers) to build our knowledge base and shared dialogue for the important sector-wide changes that lie ahead in relation to strengthening our service delivery responses to domestic and family violence.
On Wednesday 24 May 2017, nearly 70 stakeholders from across the ACT Alcohol and Other Drugs (AOD) and Domestic and Family Violence (DFV) sectors attended the ATODA Promoting Safety and Prioritising Domestic and Family Violence in the ACT Alcohol and Other Drug Sector Symposium.
The Symposium provided the first known opportunity in the ACT to promote an open dialogue, critical reflection and exchange of ideas about AOD sector understandings of and responses to DFV.
Delegates were Welcomed to Country by Aunty Agnes Shea, and welcomed to the Symposium by the ATODA CEO, Carrie Fowlie. Presenters on the day included:
- Amanda Bode—Project Manager ATODA—overview of the ACT AOD DFV Project and reflections on the AOD sector’s experiences with undertaking transformational change
- Sione Crawford and Eleanor Morrison—Community Representatives and Symposium Discussants—how violence is experienced by people who use AOD and reflections on the day from a community perspective
- Marcia Williams—Chair, Domestic Violence Prevention Council & CEO, Women’s Centre for Health Matters—overview of policy and service delivery context of DFV in the ACT
- Dr Anna Olsen—Senior Lecturer, Research School of Population Health ANU—evidence for the links between AOD and DFV
- Anke van der Sterren—Researcher, ATODA—understanding the AOD sector and people who access AOD services
- Dr Nicole Lee—Director, 360Edge & Adjunct Associate Professor, National Drug Institute, Curtin University—considerations for working with women who have experienced DFV
- Dr Stefan Gruenert—CEO, Odyssey House Victoria—approaches to working with men who have used or are at risk of using DFV
- Trevor King—Director of Programs, UnitingCare ReGen Alcohol and Drug Service—a specialist AOD service’s reflections on better responding to DFV
A Symposium report including the themes, summaries of the presentations, and evaluation of the day is available here. Slides from a number of presentations are available, and can be accessed by selecting the highlighted title in the list above.
For more information contact the ATODA team on firstname.lastname@example.org or (02) 6249 6358